|
1
|
Jia J, Huang X, Zhang WF and Zhao YF:
Human monocyte-derived hemangioma-like endothelial cells: Evidence
from an in vitro study. Cardiovasc Pathol. 17:212–218.
2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Spence-Shishido AA, Good WV, Baselga E and
Frieden IJ: Hemangiomas and the eye. Clin Dermatol. 33:170–182.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Boye E, Jinnin M and Olsen BR: Infantile
hemangioma: Challenges, new insights, and therapeutic promise. J
Craniofac Surg. 20 (Suppl 1):S678–S684. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang K, Wang F, Huang J, Lou Y, Xie J, Li
H, Cao D and Huang X: Insulin-like growth factor 2 promotes the
adipogenesis of hemangioma-derived stem cells. Exp Ther Med.
17:1663–1669. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Sun P, Feng Y, Guo H, Li R, Yu P, Zhou X,
Pan Z, Liang Y, Yu B, Zheng Y, et al: MiR-34a inhibits cell
proliferation and induces apoptosis in human nasopharyngeal
carcinoma by targeting lncRNA MCM3AP-AS1. Cancer Manag Res.
12:4799–4806. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhao F, Yang X, Xu G, Bi J, Lv R and Huo
R: Propranolol suppresses HUVEC viability, migration, VEGF
expression, and promotes apoptosis by downregulation of miR-4295. J
Cell Biochem. 120:6614–6623. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zeng Z, Liu S, Cai J, Li Z, Wu H, Chen H
and Huang Y: miR-501 promotes hemangioma progression by targeting
HOXD10. Am J Transl Res. 11:2439–2446. 2019.PubMed/NCBI
|
|
10
|
Liu C, Zhao Z, Ji Z, Jiang Y and Zheng J:
MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem
Cells. Cell Struct Funct. 44:41–50. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Long ZQ and Wang YD: miR-195-5p suppresses
lung cancer cell proliferation, migration, and invasion via FOXK1.
Technol Cancer Res Treat. 19(1533033820922587)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang HR, Guo XY, Liu XY and Song X:
Down-regulation of lncRNA CASC9 aggravates sepsis-induced acute
lung injury by regulating miR-195-5p/PDK4 axis. Inflamm Res.
69:559–568. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shen S, Li K, Liu Y, Liu X, Liu B, Ba Y
and Xing W: Silencing lncRNA AGAP2-AS1 upregulates miR-195-5p to
repress migration and invasion of EC cells via the decrease of
FOSL1 expression. Mol Ther Nucleic Acids. 20:331–344.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang J, Zhao T, Tian L and Li Y: LncRNA
OIP5-AS1 promotes the proliferation of hemangioma vascular
endothelial cells via regulating miR-195-5p/NOB1 axis. Front
Pharmacol. 10(449)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jiang H, Jin C, Liu J, Hua D, Zhou F, Lou
X, Zhao N, Lan Q, Huang Q, Yoon JG, et al: Next generation
sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma
proliferation and activates TGF-β signaling by targeting SKI.
OMICS. 18:196–206. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schweighofer CD, Coombes KR, Barron LL,
Diao L, Newman RJ, Ferrajoli A, O'Brien S, Wierda WG, Luthra R,
Medeiros LJ, et al: A two-gene signature, SKI and SLAMF1, predicts
time-to-treatment in previously untreated patients with chronic
lymphocytic leukemia. PLoS One. 6(e28277)2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Heider TR, Lyman S, Schoonhoven R and
Behrns KE: Ski promotes tumor growth through abrogation of
transforming growth factor-beta signaling in pancreatic cancer. Ann
Surg. 246:61–68. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhao X, Fang Y, Wang X, Yang Z, Li D, Tian
M and Kang P: Knockdown of Ski decreases osteosarcoma cell
proliferation and migration by suppressing the PI3K/Akt signaling
pathway. Int J Oncol. 56:206–218. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang C, Dowd DR, Staal A, Gu C, Lian JB,
van Wijnen AJ, Stein GS and MacDonald PN: Nuclear coactivator-62
kDa/Ski-interacting protein is a nuclear matrix-associated
coactivator that may couple vitamin D receptor-mediated
transcription and RNA splicing. J Biol Chem. 278:35325–35336.
2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
O TM, Tan M, Tarango M, Fink L, Mihm M, Ma
Y and Waner M: Differential expression of SKI oncogene protein in
hemangiomas. Otolaryngol Head Neck Surg. 141:213–218.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR,
Ding Y, Liang JQ, Li TT and Zhao J: MiR-497-5p, miR-195-5p and
miR-455-3p function as tumor suppressors by targeting hTERT in
melanoma A375 cells. Cancer Manag Res. 10:989–1003. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jin Y, Wang M, Hu H, Huang Q, Chen Y and
Wang G: Overcoming stemness and chemoresistance in colorectal
cancer through miR-195-5p-modulated inhibition of notch signaling.
Int J Biol Macromol. 117:445–453. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang J and Lou W: A Key mRNA-miRNA-lncRNA
competing endogenous RNA triple sub-network linked to diagnosis and
prognosis of hepatocellular carcinoma. Front Oncol.
10(340)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zeng Z, Chen H, Cai J, Huang Y and Yue J:
IL-10 regulates the malignancy of hemangioma-derived endothelial
cells via regulation of PCNA. Arch Biochem Biophys.
688(108404)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sarwar MS, Xia YX, Liang ZM, Tsang SW and
Zhang HJ: Mechanistic pathways and molecular targets of
plant-derived anticancer ent-kaurane diterpenes.
Biomolecules. 10(144)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Alaeddini M and Etemad-Moghadam S: Are ski
and SnoN involved in the tumorigenesis of oral squamous cell
carcinoma through Smad4? Appl Immunohistochem Mol Morphol.
27:626–630. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Baranek C, Dittrich M, Parthasarathy S,
Bonnon CG, Britanova O, Lanshakov D, Boukhtouche F, Sommer JE,
Colmenares C, Tarabykin V and Atanasoski S: Protooncogene Ski
cooperates with the chromatin-remodeling factor Satb2 in specifying
callosal neurons. Proc Natl Acad Sci USA. 109:3546–3551.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang Y, Liu L, Peng W, Liu H, Liang L,
Zhang X, Mao Y, Zhou X, Shi M, Xiao Y, et al: Ski-related novel
protein suppresses the development of diabetic nephropathy by
modulating transforming growth factor-β signaling and microRNA-21
expression. J Cell Physiol. 234:17925–17936. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Colmenares C, Heilstedt HA, Shaffer LG,
Schwartz S, Berk M, Murray JC and Stavnezer E: Loss of the SKI
proto-oncogene in individuals affected with 1p36 deletion syndrome
is predicted by strain-dependent defects in Ski-/- mice.
Nat Genet. 30:106–109. 2002.PubMed/NCBI View
Article : Google Scholar
|
